| 100017-3 | Perioperative nursing data set outcomes panel |
| 100062-9 | Standard Dermatology Outcome Measures panel |
| 100066-0 | Specular microscopy panel |
| 100088-4 | Taenia solium larva Ab bands panel - Serum (immunoblot) |
| 100092-6 | Trypanosoma cruzi Ab bands panel - Serum (immunoblot) |
| 100105-6 | Filaria IgG and IgM panel - Serum |
| 100109-8 | Leishmania sp Ab bands panel - Serum (immunoblot) |
| 100112-2 | Fasciola sp Ab bands panel - Serum (immunoblot) |
| 100113-0 | Helicobacter pylori Ab panel - Serum |
| 100120-5 | Chlamydia trachomatis Ab panel - Serum |
| 100122-1 | Chlamydophila pneumoniae Ab panel - Serum |
| 100125-4 | Chlamydophila psittaci Ab panel - Serum |
| 100126-2 | Bordetella pertussis Ab.IgG panel - Serum |
| 100127-0 | Campylobacter sp Ab panel - Serum |
| 100128-8 | Cryptococcus sp Ag panel - Serum |
| 100147-8 | Toxoplasma gondii Ab bands panel - Serum (immunoblot) |
| 100148-6 | Schistosoma sp Ab bands panel - Serum (immunoblot) |
| 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |
| 100159-3 | Knee Society Score pre-op panel |
| 100197-3 | Exercise activity and pain severity panel |
| 100203-9 | Knee Society Score post-op panel |
| 100224-5 | Cardiac left ventricular segmental wall motion (echo panel) |
| 100230-2 | Routine prenatal assessment panel |
| 100232-8 | Impacts of Events Scale-Revised panel |
| 100280-7 | Five Facet Mindfulness Questionnaire panel |
| 100283-1 | Harris Hip Score panel |
| 100302-9 | Time period start and end panel Unspecified body region |
| 100307-8 | Behavioral screening elder mistreatment |
| 100340-9 | Range of motion panel Hip |
| 100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen (naa with probe detection) |
| 100353-2 | Norwalk Community Health Center Screening Tool |
| 100360-7 | Brief Resilience Scale panel |
| 100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma (lc/ms/ms) |
| 100382-1 | FDA package insert REMS addressed risk |
| 100428-2 | Carnitine free and total and acylcarnitine panel - Urine |
| 100429-0 | LRBA deficiency panel - Blood |
| 100652-7 | Pure tone bone conduction threshold audiometry panel |
| 100653-5 | Pure tone air conduction threshold audiometry panel |
| 100662-6 | Cortisol free and total panel - Serum or Plasma |
| 100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat (naa with probe detection) |
| 100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |
| 100734-3 | traMADol and Metabolites Panel - Urine (confirmatory method) |
| 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |
| 100747-5 | Legionella serogroup panel - Specimen |
| 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |
| 100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF (isoelectric focusing) |
| 100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS |
| 100766-5 | Center for Epidemiologic Studies Depression Scale panel |
| 100821-8 | National POLST form: portable medical order panel |
| 100847-3 | Gas and ammonia panel - Arterial blood |
| 100848-1 | Cell count and Differential panel - Amniotic fluid (manual count) |
| 100866-3 | Febrile antibody profile |
| 100890-3 | Poxvirus DNA panel |
| 100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |
| 100898-6 | Lipid panel - Serum or Plasma |
| 100900-0 | Enterobacteriaceae.carbapenem resistance panel - Anal (organism specific culture) |
| 100903-4 | Yeast and Candida sp identification panel - Specimen (organism specific culture) |
| 100904-2 | Urinary tract pathogens panel - Urine (culture) |
| 100912-5 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel |
| 100913-3 | Staph aureus and MRSA screening panel - Specimen (organism specific culture) |
| 100921-6 | User satisfaction panel |
| 100922-4 | Privacy panel |
| 100928-1 | Digital confidence panel |
| 100934-9 | Personal safety panel |
| 100940-6 | Neighbor relationships panel |
| 100951-3 | Loneliness Office of National Statistics panel |
| 100952-1 | Product confidence panel |
| 100958-8 | Digital readiness panel |
| 100962-0 | Dengue virus Ab.IgG Panel - Serum, Plasma or Blood |
| 100968-7 | Bovine tuberculosis comparative cervical test panel - Skin |
| 100970-3 | Portable medical order completion information |
| 100971-1 | Clinical record panel |
| 100972-9 | Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose (naa with non-probe detection) |
| 100987-7 | Lymphocyte T-cell and B-cell and Natural killer subsets panel - Cerebral spinal fluid |
| 100990-1 | Fathers Blood group antigens panel |
| 100994-3 | B-cell CD19 and CD20 subsets panel - Blood (flow cytometry (fc)) |
| 100997-6 | Respiratory Allergen Panel, Area 5 - Serum |
| 100998-4 | Cortisol post dose insulin IV panel - Serum or Plasma |
| 100999-2 | Somatotropin post dose insulin IV panel - Serum or Plasma |
| 101002-4 | Monkeypox virus sequencing panel - Specimen (sequencing) |
| 101104-8 | Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11 during assessment period |
| 101105-5 | MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set during assessment period |
| 101106-3 | MDS v3.0 - RAI v1.18.11 - Nursing home quarterly (NQ) item set during assessment period |
| 101107-1 | MDS v3.0 - RAI v1.18.11 - Nursing home discharge (ND) item set during assessment period |
| 101108-9 | MDS v3.0 - RAI v1.18.11 - Nursing home and Swing bed tracking (NT and ST) item set |
| 101109-7 | MDS v3.0 - RAI v1.18.11 - Nursing home part A PPS discharge (NPE) item set during assessment period |
| 101110-5 | MDS v3.0 - RAI v1.18.11 - Nursing home PPS (NP) item set during assessment period |
| 101111-3 | MDS v3.0 - RAI v1.18.11 - Interim Payment Assessment (IPA) item set during assessment period |
| 101112-1 | MDS v3.0 - RAI v1.18.11 - Swing bed PPS (SP) item set during assessment period |
| 101113-9 | MDS v3.0 - RAI v1.18.11 - Swing bed discharge (SD) item set during assessment period |
| 101132-9 | Glucose post XXX challenge panel - Serum or Plasma |
| 101144-4 | Ustekinumab and Ustekinumab Ab panel - Serum or Plasma |
| 101146-9 | Monocyte subsets panel - Blood (flow cytometry (fc)) |
| 101172-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis rRNA panel - Specimen (naa with probe detection) |
| 101209-5 | Hantavirus IgG panel - Serum or Plasma (line blot) |
| 101214-5 | Hantavirus IgM panel - Serum or Plasma (line blot) |
| 101258-2 | MDS v3.0 - RAI v1.18.11 - Identification Information during assessment period |
| 101259-0 | MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision during assessment period |
| 101260-8 | MDS v3.0 - RAI v1.18.11 - Cognitive Patterns during assessment period |
| 101261-6 | MDS v3.0 - RAI v1.18.11 - Mood during assessment period |